Brighton Jones LLC’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-15,626
Closed -$408K – 505
2022
Q1
$408K Buy
15,626
+230
+1% +$6.53K 0.02% 310
2021
Q4
$610K Hold
15,396
– – 0.03% 241
2021
Q3
$770K Sell
15,396
-14,054
-48% -$766K 0.04% 191
2021
Q2
$1.64M Buy
29,450
+15,396
+110% +$820K 0.08% 107
2021
Q1
$657K Buy
+14,054
New +$681K 0.04% 199

Other funds holding HCAT

Brighton Jones LLC's HCAT Position: Q2 2022 in Review

Brighton Jones LLC sold out of Health Catalyst (HCAT) in Q2 2022, closing a stake of 15,626 shares — an estimated $408K sold.

Brighton Jones LLC first reported a position in HCAT in Q1 2021 and held it in 5 quarters. The position peaked at $1.64M in Q2 2021. 179 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.

  • Brighton Jones LLC reported no remaining Health Catalyst position as of Q2 2022 after selling out during the quarter.
  • Brighton Jones LLC sold 15,626 Health Catalyst shares in Q2 2022, an estimated $408K.
  • Brighton Jones LLC first reported a position in Health Catalyst in Q1 2021 and held it in 5 quarters.
  • Brighton Jones LLC's Health Catalyst position peaked at $1.64M in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.

Based on Brighton Jones LLC's 13F filing for Q2 2022, filed 4 Aug 2022.